Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification

Lyndia C. Brumback, Richard Kronmal, Susan R. Heckbert, Hanyu Ni, W. Gregory Hundley, Joao Lima, David A. Bluemke

Research output: Contribution to journalArticle

Abstract

Methods to index left ventricular (LV) mass, measured by cardiovascular magnetic resonance (CMR), for body size have not been investigated. The purposes of this study were to develop allometric indices for LV mass measured by CMR and compare estimates of the prevalence and predictive value of LV hypertrophy defined by a new allometric height-weight index, LV mass/body surface area (BSA), height indices (a new allometric height index; and previously derived indices from echocardiographic measurements: LV mass/height2, LV mass/height2.7), and non-indexed LV mass. 5,004 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) with CMR measurements of LV mass and no clinical cardiovascular disease at baseline were followed for a median of 4.1 years. The new indices and limits for hypertrophy (95th percentile) were derived from 822 normal-weight, normotensive, non-diabetic MESA participants. 107 events (coronary heart disease or stroke) were observed. The estimated prevalence of hypertrophy at baseline and hazard ratio for event associated with hypertrophy were 8% and 2.4 with the new allometric height-weight index, 11% and 2.2 with LV mass/BSA, 23-24% and 2.0-2.1 with height indices, and 20% and 1.7 with non-indexed LV mass. A statistically significant difference was detected between the hazard ratios based on the new height-weight index and non-indexed LV mass. The prevalence of hypertrophy is higher for indices that do not account for weight. The predictive value of hypertrophy is significantly better with the new allometric height-weight index than with non-indexed LV mass and may be better than indices without weight.

Original languageEnglish (US)
Pages (from-to)459-468
Number of pages10
JournalInternational Journal of Cardiovascular Imaging
Volume26
Issue number4
DOIs
StatePublished - Apr 2010

Fingerprint

Body Size
Left Ventricular Hypertrophy
Magnetic Resonance Spectroscopy
Hypertrophy
Weights and Measures
Body Surface Area
Atherosclerosis
Coronary Disease
Cardiovascular Diseases
Stroke

Keywords

  • Cardiovascular risk
  • Hypertension
  • Hypertrophy
  • LV mass index
  • Magnetic resonance imaging
  • Obesity

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification. / Brumback, Lyndia C.; Kronmal, Richard; Heckbert, Susan R.; Ni, Hanyu; Hundley, W. Gregory; Lima, Joao; Bluemke, David A.

In: International Journal of Cardiovascular Imaging, Vol. 26, No. 4, 04.2010, p. 459-468.

Research output: Contribution to journalArticle

Brumback, Lyndia C. ; Kronmal, Richard ; Heckbert, Susan R. ; Ni, Hanyu ; Hundley, W. Gregory ; Lima, Joao ; Bluemke, David A. / Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification. In: International Journal of Cardiovascular Imaging. 2010 ; Vol. 26, No. 4. pp. 459-468.
@article{caae3c4fcb454290979466d8fe90b650,
title = "Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification",
abstract = "Methods to index left ventricular (LV) mass, measured by cardiovascular magnetic resonance (CMR), for body size have not been investigated. The purposes of this study were to develop allometric indices for LV mass measured by CMR and compare estimates of the prevalence and predictive value of LV hypertrophy defined by a new allometric height-weight index, LV mass/body surface area (BSA), height indices (a new allometric height index; and previously derived indices from echocardiographic measurements: LV mass/height2, LV mass/height2.7), and non-indexed LV mass. 5,004 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) with CMR measurements of LV mass and no clinical cardiovascular disease at baseline were followed for a median of 4.1 years. The new indices and limits for hypertrophy (95th percentile) were derived from 822 normal-weight, normotensive, non-diabetic MESA participants. 107 events (coronary heart disease or stroke) were observed. The estimated prevalence of hypertrophy at baseline and hazard ratio for event associated with hypertrophy were 8{\%} and 2.4 with the new allometric height-weight index, 11{\%} and 2.2 with LV mass/BSA, 23-24{\%} and 2.0-2.1 with height indices, and 20{\%} and 1.7 with non-indexed LV mass. A statistically significant difference was detected between the hazard ratios based on the new height-weight index and non-indexed LV mass. The prevalence of hypertrophy is higher for indices that do not account for weight. The predictive value of hypertrophy is significantly better with the new allometric height-weight index than with non-indexed LV mass and may be better than indices without weight.",
keywords = "Cardiovascular risk, Hypertension, Hypertrophy, LV mass index, Magnetic resonance imaging, Obesity",
author = "Brumback, {Lyndia C.} and Richard Kronmal and Heckbert, {Susan R.} and Hanyu Ni and Hundley, {W. Gregory} and Joao Lima and Bluemke, {David A.}",
year = "2010",
month = "4",
doi = "10.1007/s10554-010-9584-5",
language = "English (US)",
volume = "26",
pages = "459--468",
journal = "International Journal of Cardiovascular Imaging",
issn = "1569-5794",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification

AU - Brumback, Lyndia C.

AU - Kronmal, Richard

AU - Heckbert, Susan R.

AU - Ni, Hanyu

AU - Hundley, W. Gregory

AU - Lima, Joao

AU - Bluemke, David A.

PY - 2010/4

Y1 - 2010/4

N2 - Methods to index left ventricular (LV) mass, measured by cardiovascular magnetic resonance (CMR), for body size have not been investigated. The purposes of this study were to develop allometric indices for LV mass measured by CMR and compare estimates of the prevalence and predictive value of LV hypertrophy defined by a new allometric height-weight index, LV mass/body surface area (BSA), height indices (a new allometric height index; and previously derived indices from echocardiographic measurements: LV mass/height2, LV mass/height2.7), and non-indexed LV mass. 5,004 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) with CMR measurements of LV mass and no clinical cardiovascular disease at baseline were followed for a median of 4.1 years. The new indices and limits for hypertrophy (95th percentile) were derived from 822 normal-weight, normotensive, non-diabetic MESA participants. 107 events (coronary heart disease or stroke) were observed. The estimated prevalence of hypertrophy at baseline and hazard ratio for event associated with hypertrophy were 8% and 2.4 with the new allometric height-weight index, 11% and 2.2 with LV mass/BSA, 23-24% and 2.0-2.1 with height indices, and 20% and 1.7 with non-indexed LV mass. A statistically significant difference was detected between the hazard ratios based on the new height-weight index and non-indexed LV mass. The prevalence of hypertrophy is higher for indices that do not account for weight. The predictive value of hypertrophy is significantly better with the new allometric height-weight index than with non-indexed LV mass and may be better than indices without weight.

AB - Methods to index left ventricular (LV) mass, measured by cardiovascular magnetic resonance (CMR), for body size have not been investigated. The purposes of this study were to develop allometric indices for LV mass measured by CMR and compare estimates of the prevalence and predictive value of LV hypertrophy defined by a new allometric height-weight index, LV mass/body surface area (BSA), height indices (a new allometric height index; and previously derived indices from echocardiographic measurements: LV mass/height2, LV mass/height2.7), and non-indexed LV mass. 5,004 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) with CMR measurements of LV mass and no clinical cardiovascular disease at baseline were followed for a median of 4.1 years. The new indices and limits for hypertrophy (95th percentile) were derived from 822 normal-weight, normotensive, non-diabetic MESA participants. 107 events (coronary heart disease or stroke) were observed. The estimated prevalence of hypertrophy at baseline and hazard ratio for event associated with hypertrophy were 8% and 2.4 with the new allometric height-weight index, 11% and 2.2 with LV mass/BSA, 23-24% and 2.0-2.1 with height indices, and 20% and 1.7 with non-indexed LV mass. A statistically significant difference was detected between the hazard ratios based on the new height-weight index and non-indexed LV mass. The prevalence of hypertrophy is higher for indices that do not account for weight. The predictive value of hypertrophy is significantly better with the new allometric height-weight index than with non-indexed LV mass and may be better than indices without weight.

KW - Cardiovascular risk

KW - Hypertension

KW - Hypertrophy

KW - LV mass index

KW - Magnetic resonance imaging

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=77951104718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951104718&partnerID=8YFLogxK

U2 - 10.1007/s10554-010-9584-5

DO - 10.1007/s10554-010-9584-5

M3 - Article

C2 - 20107905

AN - SCOPUS:77951104718

VL - 26

SP - 459

EP - 468

JO - International Journal of Cardiovascular Imaging

JF - International Journal of Cardiovascular Imaging

SN - 1569-5794

IS - 4

ER -